Journal of Medicine and Life · 2023 · 31 citations · 24 references
MedicinePathobiologyPharmacologyApoptosisInflammationRenal PathophysiologyAcute Kidney InjuryAnti-inflammatory PharmacologyNeuroprotectionOxidative Stress In InflammationRenal IschemiaRenal Ischemic InjuryAnti-apoptotic AgentsBiomarkers Of Ischemic InjuryBiomarkers Of Renal IschemiaIschemic Organ InjuryOxidative Stress In Ischemia-reperfusion InjuryOxidative Stress InjuryRenal Oxidative StressRenal Tissue Injury
Ischemia-reperfusion injury (IRI) is a major contributor to acute and chronic kidney failure, heart failure, and ischemic stroke. This study aimed to investigate the therapeutic potential of Iberin, known for its anti-inflammatory, antioxidant, and antiapoptotic properties, in a rat model of renal IRI. Twenty-four adult male rats were randomly divided into four groups: Group I (Sham group) underwent laparotomy without IRI induction; Group II (Control group) underwent laparotomy followed by renal artery clamping for 30 minutes to induce ischemia, followed by 2 hours of reperfusion; Group III (Iberin treatment group) received a pre-injection of Iberin (15 mg/kg) and underwent 30 minutes of ischemia followed by 2 hours of reperfusion; and Group IV (Vehicle-treated group) received the vehicle (ethanol) 1 hour prior to ischemia and reperfusion induction. Iberin was diluted with ethanol. Biomarkers associated with inflammation, oxidative stress, and apoptosis were measured using enzyme-linked immunosorbent assay. Iberin treatment significantly reduced levels of inflammatory cytokines interleukin-1β (IL-1β) and IL-6, Bcl-2-associated X protein (BAX), tumor necrosis factor α (TNF-α), nuclear factor kappa p56, high mobility group B1, and neutrophil gelatinase-associated lipocalin. Moreover, Iberin increased levels of heat shock protein and Bcl2 compared to the control and vehicle groups. Iberin treatment prolonged the ischemic tolerance of renal tissue, potentially preventing or delaying irreversible injuries. These findings highlight the potential of Iberin as a promising candidate for mitigating renal injury caused by ischemia-reperfusion, due to its ability to modulate inflammatory markers.
24
High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
Martin Andrassy, H. Christian Volz, John C. Igwe et al. · Circulation · 2008 · 608 citations
Rex Munday, Christine M. Munday · Journal of Agricultural and Food Chemistry · 2004 · 202 citations